Clinical Trial

Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 10, 2023 (before its estimated December 14, 2023 completion). Its status may not reflect the trial's current state.
Summary
External radiation given in 25 fractions or so together with weekly chemotherapy and followed by 3 or 4 fractions of brachytherapy is the standard of care for patients with locally advanced cervical cancer. This study investigates the role of shortened external radiotherapy regimen (hypofractionated radiotherapy) by randomizing patients to this experimental regimen versus the standard of care.The purpose of this study is to access the feasibility of patient accrual to this trial in the Canadian setting and to provide an initial evaluation of cancer response and treatment tolerability.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-10-09; most recent amendment 2023-05-09.
Status change: Not Yet Recruiting → Recruiting 2021-02-16
Trial Details
NCT Number NCT04583254
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: Academic Medical Organization of Southwestern Ontario
Conditions Cervical Cancer
Enrollment 48 participants
Start Date 2021-02-04
Primary Completion 2023-12-14 (estimated)
Study Completion 2028-12-14 (estimated)
Updated on ClinicalTrials.gov 2023-05-10